RFID ledger for stents and implants, from vendor shelf to patient bill
TL;DR Stenttrack tags the expensive implants that vendors leave on consignment in cath labs and operating theatres, then follows each one to the patient and the bill. Hospitals pay a subscription per site. The pitch is simple - no lost implants, no expired stock used and no bill above an NPPA price cap.
India's medical supply chain goes blind once stock leaves the distributor. A 2022 GS1 India and AHPI study found over 80% of drug and device makers cannot see their products at the point of care, more than half lose 1% of sales to expiry and pilferage, and about 69% cannot recall a product beyond the distributor[1].
Implants are where this hurts the most. Stents, knee components and trauma kits often sit in hospitals on consignment, and the vendor owns them until they're used. Counting is manual, and fights over what was used, by whom and at what price are likely common, though I found no study that measures them.
Pricing is policed too. When NPPA capped stent prices in 2017, it said hospitals were charging 10 to 15 times the base price[2].
First, the important bit - Stenttrack does inventory and billing reconciliation only. It never touches patient care and makes no clinical claims, so it is not a medical device. Its billing checks follow NPPA ceiling-price notifications under the Drugs (Prices Control) Order 2013[3].
Each implant gets an RFID label when the vendor delivers it. Readers at the cath lab and OT store log what goes in and out. When a nurse scans an implant at the table it's tied to the patient's admission, and the system checks the expiry date and compares the billed price with the current ceiling. At month end the hospital and the vendor see the same list of what was used, returned and still on the shelf.
The original idea put RFID on every item with predictive analytics for all supplies, and that doesn't pay in a typical Indian hospital where a 10 ml syringe costs under ₹7 to buy[4]. Shortages also often start upstream, with makers who can't see hospital stock at all[1]. So the tags go only on items worth thousands of rupees each, and reorder alerts come from plain usage counts.
The hospital pays. That means the materials manager and the CFO, with the cath lab or ortho head as the daily user. Implant distributors are a second buyer, because consignment stock they can't count costs them money. I found no public price for hospital RFID tracking in India, so start by testing a monthly fee per site plus a one-time hardware charge.
Price caps keep moving. NPPA revised stent ceilings from 1 April 2026, to ₹39,186.03 for drug-eluting and ₹10,762.15 for bare-metal stents[3], and extended knee-implant caps to 15 November 2026[5]. In September 2026 a Maharashtra FDA review found consumables marked up as much as 2,841%, and the Centre called for a price review[4]. Billing is getting a lot more scrutiny.
Nobody publishes a figure for India's hospital implant-tracking market, or a verified count of stents and knee implants used each year. The firmest signals are the GS1/AHPI findings on lost visibility and expiry losses[1].
The closest neighbour is a Japanese labelling company, which says about 80% of orthopaedic implant loan kits in Australia and New Zealand carry its RFID tags[6]. That's a vendor claim from a different health system, so treat it as a hint and not a number.
That labelling company's system in Australia tracks implant loan kits with RFID, checks expiry before use and keeps an audit trail of swaps in theatre[6]. A large Indian medical-supplies marketplace sells equipment and consumables, including orthopaedic and cardiology lines, to Indian hospitals, but its site shows no tracking or consignment product[7]. Hospital software suites usually come with a stores module, mostly barcode-based.
I found no Indian firm offering RFID implant tracking tied to NPPA price checks, though my search was limited.
| Difficulty | Hard (52/100) |
| Starting capital | ₹1.2–2.4 Cr |
| Time to launch | 9–12 months |
The tags and readers are bought in, so that's not the problem. The hard part is getting vendors to label at delivery, fitting scanning into a busy cath lab without slowing anyone down and linking to each hospital's billing system. Sales cycles are long because the hospital and its vendors both have to say yes.
There's no special operating licence while Stenttrack only tracks stock and checks bills, but the readers and the price rules still need attention.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't trust AI to settle money disputes on its own. A person should confirm every flagged mismatch before anyone tells a vendor or a patient they were overcharged.
Want to work out the AI layer for Stenttrack? Talk to Yash →
Here's what can go south -
I think this is a fair bet, but only for a founder from medical device distribution or hospital supply chain who already knows cath lab and OT staff. If you're a pure software founder then skip it.
Before you spend real money, prove the money is there - in one cath lab over 60 days, show missing or unbilled implants worth more than a year of your fee.
My estimate is ₹1.2–2.4 Cr, covering RFID readers, software, installation and the first hospital pilots. The kit has the line-by-line breakdown.
No operating licence while it only tracks stock and bills. Each reader model needs WPC type approval, and patient-linked data falls under the DPDP Act.
Yes, hospitals everywhere lose track of costly consignment stock. Price caps and radio approvals differ though, so check your local rules first.
The free Stenttrack validation kit has the line-by-line capital breakdown, the effort scoring, the price-cap and radio-approval checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for hospitals and distributors, and 5 assumptions to test. Download the kit →
Thinking of building Stenttrack or something close to it? The make-or-break bit is getting one hospital and its implant vendors to agree to a shared ledger, and that's the kind of thing I help founders with. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.